发明名称 |
Triphasic oral contraceptive |
摘要 |
A method of contraception in which an estrogen and a progestogen are administered daily in a three phase sequence for 21 days is disclosed. In the first phase a combination of an estrogen and a progestogen in a low but contraceptively effective daily dosage corresponding in estrogenic activity to 0.02-0.05 mg of 17 alpha -ethinylestradiol and in progestogenic activity to 0.065-0.75 mg of norethindrone is administered for 5-8 days; followed by the administering of the same dosage of estrogen and a progestogen corresponding in progestogenic activity to 0.25-1.0 mg of norethindrone for 7-11 days; followed by the administering of the same dosage of estrogen and a progestogen corresponding in progestogenic activity to 0.35-2.0 mg of norethindrone for 3-7 days; followed by 6-8 days without administering either an estrogen or a progestogen.
|
申请公布号 |
US4544554(A) |
申请公布日期 |
1985.10.01 |
申请号 |
US19840607038 |
申请日期 |
1984.05.04 |
申请人 |
ORTHO PHARMACEUTICAL CORPORATION |
发明人 |
PASQUALE, SAMUEL A. |
分类号 |
A61K31/565;(IPC1-7):A61K31/56 |
主分类号 |
A61K31/565 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|